Home › Urothelial (Transitional Cell) Carcinoma › Texas › Dallas
Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Dallas, TX
Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Nagre-recruitPhase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #89, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Nagre-recruitObservasyonal na pag-aaral
- UT Southwestern Medical Center, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
- Baylor, Scott and White Research Institute, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Nagre-recruitPhase 1
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Nagre-recruitPhase 2/3
- Research Site, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- Texas Oncology, P.A., Dallas
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Nagre-recruitPhase 2
- Baylor Scott and White Research Institute, Dallas
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Nagre-recruitPhase 3
- Research Site, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Nagre-recruitPhase 2
- Texas Oncology - DFW, Dallas
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Nagre-recruit
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Nagre-recruitObservasyonal na pag-aaral
- UT Southwestern Medical Center, Dallas
Bladder Cancer Screening Trial
Nagre-recruit
- University of Texas Southwestern Medical Center, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of Texas Southwestern Medical Center, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Nagre-recruitPhase 1
- Dren Investigational Site, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Dallas
Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod
- Nashville, TN23 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX19 pag-aaral
- Edison, NJ18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Queens, NY15 pag-aaral
- Chicago, IL14 pag-aaral
- Arlington, VA12 pag-aaral
- Boston, MA11 pag-aaral
- San Antonio, TX11 pag-aaral
- Austin, TX10 pag-aaral
- Orange, CA10 pag-aaral
Iba pang pag-aaral sa Dallas
- Kanser sa Suso55 pag-aaral
- Non-Small Cell Lung Cancer52 pag-aaral
- Metastatic Cancer42 pag-aaral
- Pagkabigo ng Puso42 pag-aaral
- Kanser (lahat ng uri)37 pag-aaral
- Kanser sa Prostate36 pag-aaral
- Colorectal Cancer33 pag-aaral
- Obesity30 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser sa Baga27 pag-aaral
- Kanser sa Pantog27 pag-aaral
- Kanser ng Endometrium24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.